Page Menu

Current Research Studies

asughaliughalsgfhldgf
For more information about any of our current studies, please contact us:
Phone: 508-856-MIND(6463)
Email: MIND@umassmed.edu
 

 All of our studies are conducted at the Family Health Center, located at 26 Queen Street, Worcester, MA, 01610, which is across the street from Community Healthlink.


The Substance Use Study

Have you or someone you know been diagnosed with schizophrenia or schizoaffective disorder? Do you or that person also use alcohol, marijuana, or any other drugs?

If so, you or someone you know may be eligible to participate in a research study conducted at UMass Medical School. The purpose of this study is to see whether brexpiprazole, an investigational drug, can help reduce substance use in individuals diagnosed with schizophrenia or schizoaffective disorders. Your participation in the study will last 12 weeks. You will be compensated for your time. 


The Negative Symptoms Study

Are you experiencing negative symptoms of schizophrenia or schizoaffective disorder?

If so, you or someone you know may be eligible to participate in a research study conducted at UMass Medical School. The purpose of this study is to see if an investigational drug has effects on the negative symptosm of schizophrenia or schizoaffective disorder. Your participation will last approximately 5-months. You will be compenstated for your time.


Dual-Diagnosis Theater Research Project

Many have suggested that dramatherapy—a type of therapy in which patients work together under the guidance of a drama therapist to craft a theatre-play—can provide a beneficial means of processing and managing the mental and emotional issues related to substance use and mental illness. The Community Intervention Program (CIP) team at UMass Medical School and licensed drama therapists are working on a “dual-diagnosis” theatre program in which patients suffering from both mental health issues and substance use (“dual-diagnosis”) will be able to create and perform a play about their experience of mental illness. We will also ask participants questions about their progress and involvement in the project to help assess the effectiveness of dramatherapy. The final production of the play will be open to the general community.


The Treatment-Resistant Study 1

Are you above the age of 18 and diagnosed with schizophrenia or schizoaffective disorder?

If so, you may be eligible to participate in a research study conducted at UMass Medical School. The purpose of this research is to see if daily 80mg of telmisartan changes brain chemistry in schizophrenia patients who have not experienced a significant relief of symptoms from current medication as measured by MRI brain scans. The study will last 4 weeks, and you will be compensated for your time.


The Treatment-Resistant Study 2

Are you above the age of 18 and still experiencing symptoms of schizophrenia while taking medication? The purpose of this research is to see if daily combination treatment of L-arginine and Kuvan changes brain chemistry in people experiencing schizophrenia as measured by MRS brain scans. You will be compensated for your time.